GEOFFREY WOLFE KRYSTAL, M.D.
Osteopathic Medicine in Richmond, VA
License number
Virginia 0101043049
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
1201 Broad Rock Blvd Mcguire Veterans Affairs Medical Ctr, Richmond, VA 23249
Phone
(804) 675-5446
(804) 675-5447 (Fax)
(804) 346-8250
(804) 675-5447 (Fax)
(804) 346-8250
Personal information
See more information about GEOFFREY WOLFE KRYSTAL at radaris.comName
Address
Phone
9533 Pine Shadow Dr, Richmond, VA 23238
Richmond, VA
1201 Broad Rock Rd, Richmond, VA 23218
2500 Turner Rd, Richmond, VA 23224
9533 Pine Shadow Dr, Richmond, VA 23233
Professional information
Dr. Geoffrey W Krystal - MD (Doctor of Medicine)
Hospitals:
1201 Broad Rock Blvd, Richmond 23249
1250 E Marshall St, Richmond 23298
Mcguire Vetrans Admin Medical Center
1201 E Broad St, Richmond 23219
1201 Broad Rock Blvd, Richmond 23249
1250 E Marshall St, Richmond 23298
Mcguire Vetrans Admin Medical Center
1201 E Broad St, Richmond 23219
1250 E Marshall St, Richmond 23298
Mcguire Vetrans Admin Medical Center
1201 E Broad St, Richmond 23219
1201 Broad Rock Blvd, Richmond 23249
1250 E Marshall St, Richmond 23298
Mcguire Vetrans Admin Medical Center
1201 E Broad St, Richmond 23219
Education:
Medical Schools
University Of Miami School Of Medicine
Graduated: 1982
University Of Miami School Of Medicine
Graduated: 1982
Geoffrey Krystal, Richmond VA
Specialties:
Internal Medicine, Medical Oncology, Hematology & Oncology
Work:
Hunter Holmes Mcguire Va Medical Center
1201 Broad Rock Blvd, Richmond, VA 23286
1201 Broad Rock Blvd, Richmond, VA 23286
Education:
University of Miami(1982)
Geoffrey Wolfe Krystal, Richmond VA
Specialties:
Oncologist
Address:
1201 Broad Rock Blvd, Richmond, VA 23249
Education:
University of Miami, Miller School of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Combination Of A) N-{5-[4-(4-Methyl-Piperazino-Methyl)-Benzoylamido]2-Methylphenyl}-4- (3-Pyridyl)-2-Pyrimidine-Amine And B) A Histone Deacetylase Inhibitor For The Treatment Of Leukemia
US Patent:
2006010, May 11, 2006
Filed:
Sep 10, 2003
Appl. No.:
10/527553
Inventors:
Paul Dent - Glen Allen VA, US
Steven Grant - Richmond VA, US
Geoffrey Krystal - Richmond VA, US
Chunrong Yu - Rochester MN, US
Steven Grant - Richmond VA, US
Geoffrey Krystal - Richmond VA, US
Chunrong Yu - Rochester MN, US
International Classification:
A61K 38/12, A61K 31/506, A61K 31/405, A61K 31/19
US Classification:
514009000, 514252180, 514419000, 514557000, 514575000
Abstract:
The invention pertains to a combination of a histone deacetylase inhibitor and N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine or a pharmaceutically acceptable salt thereof for simultaneous, separate or sequential use for the treatment of leukemia and especially N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-resistant leukemia.
Combination Of Glivec (Sti571) With A Cyclin-Dependent Kinase Inhibitor, Especially Flavopiridol, In The Treatment Of Cancer
US Patent:
2005017, Aug 11, 2005
Filed:
Apr 4, 2003
Appl. No.:
10/510531
Inventors:
Paul Dent - GlenAllen VA, US
Steven Grant - Richmond VA, US
Geoffrey Krystal - Richmond VA, US
Chunrong Yu - Richmond VA, US
Steven Grant - Richmond VA, US
Geoffrey Krystal - Richmond VA, US
Chunrong Yu - Richmond VA, US
International Classification:
A61K031/506
US Classification:
514252180
Abstract:
The present invention pertains to a combination for simultaneous, separate or sequential use which comprises (a) a cyclin-dependent kinase inhibitor and (b) 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide and to its use for the treatment of cancer, especially of Bcr/Abl leukemia resistant to compound of formula I.
Combination Of A) N--4-(3-Pyridyl)-2-Pyrimidine-Amine And B) A Histone Deacetylase Inhibitor For The Treatment Of Leukemia
US Patent:
2009026, Oct 22, 2009
Filed:
Jun 19, 2009
Appl. No.:
12/456669
Inventors:
Paul Dent - GlenAllen VA, US
Steven Grant - Richmond VA, US
Geoffrey Krystal - Richmond VA, US
Chunrong Yu - Rochester MN, US
Steven Grant - Richmond VA, US
Geoffrey Krystal - Richmond VA, US
Chunrong Yu - Rochester MN, US
International Classification:
A61K 31/497
US Classification:
51425218
Abstract:
The invention pertains to a combination of a histone deacetylase inhibitor and N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine or a pharmaceutically acceptable salt thereof for simultaneous, separate or sequential use for the treatment of leukemia and especially N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-resistant leukemia.